SQSTM1 and chronic myelogenous leukemia, BCR-ABL1 positive: ATG4B was identified as a direct target of miR-34a in chronic myelogenous leukemia (CML), and the knockdown of ATG4B in CML led to impaired autophagic flux with an increase in LC3II levels and accumulation of p62 [50].